NOKOMIS, Fla.--(BUSINESS WIRE)--Rainbow Biosciences, the biotechnology subsidiary of Rainbow Coral Corp. (OTCBB: RBCC), announced today that it will expand its focus on technology capable of culturing 3D cell clusters to include adult stem cells, as well. According to a report published last year by analysts as GIA, global investments in adult stem-cell research are forecast to reach $2.4 billion by 2015. That growth is being driven by technological advancements, the rising number of research groups engaged in stem cell research activities, broadening research activities and substantial investments from governments in leading global markets.
